|
|
|
|
BIOGRAPHY
Prof. dr. ir. Kathleen Claes (°1973) obtained her M.D. and Ph.D. degree in 1996 and 2003 respectively. She is associate professor at Ghent University and PI of CRIG (Cancer Research Institute Ghent). Her major research interest involves cancer predisposition and precision oncology.
She is heading the ISO15189-accredited Laboratory of Molecular Genetics at the Center for Medical Genetics (CMGG), Ghent University Hospital. She has a major expertise in molecular tests for (hereditary) cancer.
At the international level she is active in several working groups of ENIGMA (https://enigmaconsortium.org/) and CIMBA (http://cimba.ccge.medschl.cam.ac.uk/). She is workpackage leader in the ERN GENTURIS (https://www.genturis.eu/). She is chairing the BELMOLGEN working group of the Belgian Society of Human Genetics (http://www.beshg.be/) and treasurer of FAPA (https://belgianfapa.be/).
She (co-)authored more than 120 A1 publications. She is member of the editorial board of Nature Scientific Reports. She serves on the advisory boards of (inter)national funding bodies and research councils.
She is heading the ISO15189-accredited Laboratory of Molecular Genetics at the Center for Medical Genetics (CMGG), Ghent University Hospital. She has a major expertise in molecular tests for (hereditary) cancer.
At the international level she is active in several working groups of ENIGMA (https://enigmaconsortium.org/) and CIMBA (http://cimba.ccge.medschl.cam.ac.uk/). She is workpackage leader in the ERN GENTURIS (https://www.genturis.eu/). She is chairing the BELMOLGEN working group of the Belgian Society of Human Genetics (http://www.beshg.be/) and treasurer of FAPA (https://belgianfapa.be/).
She (co-)authored more than 120 A1 publications. She is member of the editorial board of Nature Scientific Reports. She serves on the advisory boards of (inter)national funding bodies and research councils.
EDUCATION AND DEGREES
- Doctor of Health Sciences, Defended July 2003 (dissertation: 'Molecular study of the BRCA1 and BRCA2 genes in a large cohort of Belgian patients with a genetic predisposition for breast and/or ovarian cancer')
- Aggregate for education (Ghent University, 1997)
- Master of Bioscience Engineering - Cell and Gene Biotechnology (Ghent University, 1996)
CO-PROMOTORSHIP
- drs Malaïka Van der Linden
- drs Kim Van Der Eecken